Overview DOMPE -MT Neurotrophic Keratitis Status: ACTIVE_NOT_RECRUITING Trial end date: 2025-09-25 Target enrollment: Participant gender: Summary TITLE: Toyos Clinic / A Phase 4 Study to Assess Longer Duration of Treatment with Cenegermin in Moderate to Severe Dry Eye-Associated Neurotrophic KeratitisPhase: PHASE4 Details Lead Sponsor: Toyos ClinicTreatments: cenegermin